Hostname: page-component-65f69f4695-z9j9t Total loading time: 0 Render date: 2025-06-29T00:43:18.565Z Has data issue: false hasContentIssue false

TP53 mutation may underlie increasing incidence of external auditory canal carcinoma

Published online by Cambridge University Press:  11 November 2024

J. S. Virk
Affiliation:
Otolaryngology and Pathology Department, Royal London Hospital, Barts NHS Health Trust, London, UK

Abstract

Background

Primary neoplasm of the external auditory canal has historically been documented to have a low incidence rate of between one and six per million internationally, with UK incidence yet to be officially cited.

Methods

Here, we report a rise in incidence at a single UK trust with seven carcinomas (six T4 external auditory canal squamous cell and one T4 basal cell) reported within an 18-month period. All tumours underwent next generation sequencing.

Results

The cases recorded represented a twofold rise in incidence in reference to international literature from a population-adjusted estimate of 0.5–3 cases for the catchment area to seven cases. All cases were treated with temporal bone resections (n = 7) and with post-operative radiotherapy in six cases. Tumour analysis showed all were TP53 mutant and human papilloma virus (HPV)/P16 negative.

Conclusion

We suggest chronic inflammation and genetic alterations as putative contributory factors in our case series and outline clinical strategies for timely detection of external auditory canal neoplasms.

Information

Type
Main Article
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of J.L.O. (1984) LIMITED.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Footnotes

Aashish Pandya takes responsibility for the integrity of the content of the paper

References

Oya, R, Takenaka, Y, Takemura, K, Ashida, N, Shimizu, K, Kitamura, T, et al. Surgery with or without postoperative radiation therapy for early-stage external auditory canal squamous cell carcinoma: a meta-analysis. Otol Neurotol 2017;38:1333–8Google Scholar
Allanson, BM, Low, T-H, Clark, JR, Gupta, R. Squamous cell carcinoma of the external auditory canal and temporal bone: an update. Head Neck Pathol 2018;12:407–18Google Scholar
Yin, M, Ishikawa, K, Honda, K, Arakawa, T, Harabuchi, Y, Nagabashi, T, et al. Analysis of 95 cases of squamous cell carcinoma of the external and middle ear. Auris Nasus Larynx 2006;33:251–7Google Scholar
Martinez Devesa, P, Willis, CM, Capper, JWR. External auditory canal pH in chronic otitis externa. Clin Otolaryngol Allied Sci 2003;28:320–4Google Scholar
Tsai, ST, Li, C, Jin, YT, Chao, WY, Su, IJ. High prevalence of human papillomavirus types 16 and 18 in middle‐ear carcinomas. Int J Cancer 1997;71:208–12Google Scholar
Lim, LH, Goh, YH, Chan, YM, et al. Malignancy of the temporal bone and external auditory canal. Otolaryngol Head Neck Surg 2000;122:882–6Google Scholar
Sato, K, Komune, N, Hongo, T, Koike, K, Niida, A, Uchi, R, et al. Genetic landscape of external auditory canal squamous cell carcinoma. Cancer Sci 2020;111:3010–19Google Scholar
Lechner, M, Sutton, L, Murkin, C, Masterson, L, O’Flynn, P, Wareing, MJ, et al. Squamous cell cancer of the temporal bone: a review of the literature. Eur Arch Otorhinolaryngol 2021;278:2225–8Google Scholar
Moody, SA, Hirsch, BE, Myers, EN. Squamous cell carcinoma of the external auditory canal: an evaluation of a staging system. Am J Otol 2000;21:582–8Google Scholar
NHS Digital. Hospital episode statistics, admitted patient care: diagnosis – England, 2022–23 [NS]. In: https://digital.nhs.uk/data-and-information/publications/statistical/hospital-admitted-patient-care-activity/2022-23 [2 December 2023]Google Scholar
NHS Digital. Hospital episode statistics, admitted patient care: diagnosis – England, 2016–17. In: https://digital.nhs.uk/data-and-information/publications/statistical/hospital-admitted-patient-care-activity/2016-17 [2 December 2023]Google Scholar
NHS Digital. Hospital episode statistics, admitted patient care: diagnosis – England, 2021–22. In: https://digital.nhs.uk/data-and-information/publications/statistical/hospital-admitted-patient-care-activity/2021-22 [2 December 2023]Google Scholar
Arriaga, M, Curtin, H, Takahashi, H, Hirsch, BE, Kamerer, DB. Staging proposal for external auditory meatus carcinoma based on preoperative clinical examination and computed tomography findings. Ann Otol Rhinol Laryngol 1990;99:714–21Google Scholar
Prasad, S, Janecka, IP. Efficacy of surgical treatments for squamous cell carcinoma of the temporal bone: a literature review. Otolaryngol Head Neck Surg 1994;110:270–80Google Scholar
Cho, RJ, Alexandrov, LB, den Breems, NY, Atanasova, VS, Farshchian, M, Purdom, E, et al. APOBEC mutation drives early‐onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa. Sci Transl Med 2018;10:eaas9668Google Scholar
Jin, YT, Tsai, ST, Li, C, Chang, KC, Yan, JJ, Chao, WY, et al. Prevalence of human papillomavirus in middle ear carcinoma associated with chronic otitis media. Am J Pathol 1997;150:1327–33Google Scholar
Masterson, L, Winder, DM, Marker, A, Sterling, JC, Sudhoff, HH, Moffat, DA, et al. Investigating the role of human papillomavirus in squamous cell carcinoma of the temporal bone. Head Neck Oncol 2013;5:22Google Scholar
Sharma, S, Kelly, TK, Jones, PA. Epigenetics in cancer. Carcinogenesis 2010;31:2736Google Scholar
Feinberg, AP, Ohlsson, R, Henikoff, S. The epigenetic progenitor origin of human cancer. Nat Rev Genet 2006;7:2133Google Scholar
Fodde, R, Smits, R, Clevers, H. APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 2001;1:5567Google Scholar
Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature 2014;511:543–50Google Scholar
Boutros, A, Cecchi, F, Tanda, ET, Croce, E, Gili, R, Arecco, L, et al. Immunotherapy for the treatment of cutaneous squamous cell carcinoma. Front Oncol 2021;11:733917Google Scholar